Convergence of metabolic risk in obesity and normal BMI: does risk disappear?
Author:
- 1 July 2026
- journal article
- Published by Elsevier in The Lancet
- Vol. 408 (10552) , 294-296
Abstract
No abstract availableFunding Information
- National Institutes of Health
This publication has 12 references indexed in Scilit:
- 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic SyndromeJACC, 2026
- Trends in Prevalence, Treatment, and Control of Cardiometabolic Risk Factors Among Adults With Hypertension in the United States, 1999-2023JACC, 2025
- Uptake of and Disparities in Semaglutide and Tirzepatide Prescribing for Obesity in the USJAMA, 2025
- Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adultsThe Lancet, 2024
- Association of Incident Cardiovascular Disease With Time Course and Cumulative Exposure to Multiple Risk FactorsJACC, 2023
- Managing Atherosclerotic Cardiovascular Risk in Young AdultsJACC, 2022
- Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart AssociationCirculation, 2021
- Achieving Optimal Population Cardiovascular Health Requires an Interdisciplinary Team and a Learning Healthcare System: A Scientific Statement From the American Heart AssociationCirculation, 2021
- Health Effects of Overweight and Obesity in 195 Countries over 25 YearsNew England Journal of Medicine, 2017
- Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participantsThe Lancet, 2014